Yongchang Zhang

Yongchang Zhang

UNVERIFIED PROFILE

Are you Yongchang Zhang?   Register this Author

Register author
Yongchang Zhang

Yongchang Zhang

Publications by authors named "Yongchang Zhang"

Are you Yongchang Zhang?   Register this Author

29Publications

364Reads

28Profile Views

EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases.

Eur J Cancer 2019 Nov 27;121:98-108. Epub 2019 Sep 27.

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China; Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.08.021DOI Listing
November 2019

Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms From Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.

Acad Radiol 2019 Sep 5. Epub 2019 Sep 5.

Department of Radiology, West China Hospital of Sichuan University, Guoxue Lane 37#, Chengdu 610041, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2019.06.012DOI Listing
September 2019

Responder of Gefitinib Plus Crizotinib in Osimertinib Failure EGFR-mutant NSCLC-Resistant With Newly Identified STRN-ALK by Next-Generation Sequencing.

J Thorac Oncol 2019 07;14(7):e143-e144

Lung Cancer and Gastrointestinal Unit, Department of Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.014DOI Listing
July 2019

Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers.

Int J Biol Sci 2019 10;15(8):1733-1742. Epub 2019 Jun 10.

Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, 650223, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/ijbs.35138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643226PMC
June 2019

Tyrosine kinase inhibitor acquired resistance mechanism alternates between EGFR and ALK in a lung adenocarcinoma patient.

Thorac Cancer 2019 May 20;10(5):1252-1255. Epub 2019 Feb 20.

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1759-7714.13015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501016PMC
May 2019

EGFR exon 21 L858R as an acquired resistance mechanism to nivolumab in a lung cancer patient originally driver gene-negative.

Thorac Cancer 2019 May 27;10(5):1256-1259. Epub 2019 Feb 27.

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1759-7714.13023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501009PMC
May 2019

Elastic Staining on Paraffin-embedded Slides of pT3N0M0 Gastric Cancer Tissue.

J Vis Exp 2019 05 1(147). Epub 2019 May 1.

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/58278DOI Listing
May 2019

Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer.

Cancer Med 2019 04 14;8(4):1434-1441. Epub 2019 Feb 14.

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488207PMC
April 2019

Identification of a Novel MET Exon 14 Skipping Variant Coexistent with EGFR Mutation in Lung Adenocarcinoma Sensitive to Combined Treatment with Afatinib and Crizotinib.

J Thorac Oncol 2019 04;14(4):e70-e72

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.11.026DOI Listing
April 2019

Comparison of PET/MRI with multiparametric MRI in diagnosis of primary prostate cancer: A meta-analysis.

Eur J Radiol 2019 Apr 21;113:225-231. Epub 2019 Feb 21.

Department of Radiology, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan Province, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2019.02.028DOI Listing
April 2019

Lung squamous carcinoma involving the lip and cheek.

Lancet Oncol 2018 12;19(12):e726

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30441-8DOI Listing
December 2018

Phase III Randomized Trial of Palonosetron and Dexamethasone With or Without Aprepitant to Prevent Nausea and Vomiting Induced by Full-dose Single-day Cisplatin-based Chemotherapy in Lung Cancer.

Clin Lung Cancer 2018 11 23;19(6):e913-e918. Epub 2018 Aug 23.

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.08.006DOI Listing
November 2018

Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer.

Onco Targets Ther 2018 15;11:6937-6945. Epub 2018 Oct 15.

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha 410013, China,

View Article

Download full-text PDF

Source
https://www.dovepress.com/crizotinib-presented-with-promisin
Publisher Site
http://dx.doi.org/10.2147/OTT.S176273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199224PMC
October 2018

Correlation of plasma erlotinib trough concentration with skin rash in Chinese NSCLC patients harboring exon 19 deletion mutation.

Cancer Chemother Pharmacol 2018 09 23;82(3):551-559. Epub 2018 Jul 23.

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, Changsha, 410011, China.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-018-3642-4
Publisher Site
http://dx.doi.org/10.1007/s00280-018-3642-4DOI Listing
September 2018

Should Crizotinib Take It All in ROS1-Positive Non-Small-Cell Lung Cancer?

J Clin Oncol 2018 Sep 13:JCO1800119. Epub 2018 Sep 13.

Liang Zeng, Nong Yang, and Yongchang Zhang, Hunan Cancer Hospital, Changsha, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.00119DOI Listing
September 2018

Lung adenocarcinoma patient progression with gastrointestinal metastasis response to subsequent tyrosine kinase inhibitors (TKIs) from re-biopsy of new occurring driver gene mutation.

J Thorac Dis 2018 Aug;10(8):E605-E611

Department of Medical Oncology, Lung Cancer and the Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha 410013, China.

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/22914/17853
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.07.97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129912PMC
August 2018

GOPC-ROS1 Rearrangement as an Acquired Resistance Mechanism to Osimertinib and Responding to Crizotinib Combined Treatments in Lung Adenocarcinoma.

J Thorac Oncol 2018 07;13(7):e114-e116

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.02.005DOI Listing
July 2018

Novel MET Exon 14 Skipping Treatment-Naïve Lung Adenocarcinoma Presented Primary Resistance to Crizotinib.

J Thorac Oncol 2018 07;13(7):e124-e126

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183025
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.02.030DOI Listing
July 2018

EGFR exon 18 DelE709_T710insD as an Acquired Resistance Mechanism to Afatinib in an Advanced EGFR exon 18 E709H Lung Adenocarcinoma.

J Thorac Oncol 2018 06;13(6):e93-e95

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.01.006DOI Listing
June 2018

Hepatic veno-occlusive disease related to Gynura segetum: A case report.

Medicine (Baltimore) 2018 Apr;97(17):e0552

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000010552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944499PMC
April 2018

Newly developed anti-angiogenic therapy in non-small cell lung cancer.

Oncotarget 2018 Feb 26;9(11):10147-10163. Epub 2017 Dec 26.

Department of Lung Cancer and Gastrointestinal Oncology Medicine, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, 410013, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.23755DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839380PMC
February 2018

The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer.

Oncotarget 2017 Dec 14;8(70):115270-115279. Epub 2017 Dec 14.

Departement of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha 410013, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.23252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777770PMC
December 2017

Elastic staining-a rejuvenated method to reassess prognosis and serosal invasion in patients with pT3N0M0 gastric cancer.

Hum Pathol 2017 07 10;65:79-84. Epub 2017 May 10.

Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, China, 410013. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.04.023DOI Listing
July 2017

GSTM1 and GSTT1 Genes are Associated With DNA Damage of p53 Gene in Coke-oven Workers.

J Occup Environ Med 2017 06;59(6):499-501

School of Public Health, Kunming Medical University (Drs He, Wang, Zhang), and Yunnan Provincial Center for Disease Control and Prevention, Kunming, China (Drs Qi, He, Zhang, Li).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JOM.0000000000000999DOI Listing
June 2017

A new glimpse of FadR-DNA crosstalk revealed by deep dissection of the E. coli FadR regulatory protein.

Protein Cell 2014 Dec 15;5(12):928-39. Epub 2014 Oct 15.

College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13238-014-0107-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259882PMC
December 2014

Cloning and analysis of the xylAB operon and characterization of xylose isomerase from Thermoanaerobacter ethanolicus.

Biotechnol Lett 2011 Mar 12;33(3):593-8. Epub 2010 Nov 12.

Jiangsu Key Laboratory for Biodiversity and Bio-resources, College of Life Sciences, Nanjing Normal University, Nanjing, 210046, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10529-010-0463-xDOI Listing
March 2011